
CAS 871543-07-6
:Fórmula:C16H23Cl2N3O2S
InChI:InChI=1S/C16H21N3O2S.2ClH/c1-12-9-18-11-14-5-3-6-15(16(12)14)22(20,21)19-8-4-7-17-10-13(19)2;;/h3,5-6,9,11,13,17H,4,7-8,10H2,1-2H3;2*1H/t13-;;/m0../s1
Chave InChI:BFOPDSJOLUQULZ-GXKRWWSZSA-N
SMILES:C[C@H]1CNCCCN1S(=O)(=O)C2=CC=CC3=C2C(=CN=C3)C.Cl.Cl
Filtrar por
Percentagem de pureza
0
100
|
0
|
50
|
90
|
95
|
100
Foram encontrados 7 produtos.
- Preços em ordem crescente
- Preços em ordem decrescente
- Menor grau de pureza
- Maior grau de pureza
- Estimativa de entrega mais rápida
H-1152 dihydrochloride
CAS:H-1152 dihydrochlorideFórmula:C16H23Cl2N3O2SPureza:99.5%Peso molecular:392.34H-1152 Dihydrochloride
CAS:Produto ControladoStability Hygroscopic
Applications ROCK Inhibitor. A cell-permeable isoquinolinesulfonamide compound that acts as a highly specific, potent, and ATP-competitive inhibitor of G-protein Rho-associated kinase (ROCK: Ki=1.6nM). Exhibits a much weaker affinity for other serine/threonine kinases (Ki=630nM for PKA 9.27 mMfor PKC, and 10.1mM for MLCK). Shown to selectively block lysophosphatidic acid-induced, but not PDBu-induced, phosphorylation of myristoylated alanine-rich C kinase substrate MARCKS (IC50=2.5nM) in NT-2 cells.
References Ikenoya, M., et al.: J. Neurochem., 81, 9 (2002), Sasaki, Y., et al.: Pharmacol. Ther., 93, 225 (2002)Fórmula:C16H21N3O2S·2ClHCor e Forma:NeatPeso molecular:392.34H-1152 2HCl
CAS:(S)-4-Methyl-5-((2-methyl-1,4-diazepan-1-yl)sulfonyl)isoquinoline dihydrochlorideFórmula:C16H23Cl2N3O2SPureza:99%Peso molecular:392.34H-1152 dihydrochloride
CAS:H-1152 2HCl: ROCK inhibitor, IC50=12 nM, Ki=1.6 nM. Blocks PKA, PKC, PKG, Aurora A, CaMKII with higher IC50s.Fórmula:C16H23Cl2N3O2SPureza:99.85%Cor e Forma:White SolidPeso molecular:392.34H-1152 (dihydrochloride)
CAS:Fórmula:C16H23Cl2N3O2SPureza:98%Cor e Forma:SolidPeso molecular:392.3437Ref: IN-DA008F7I
Produto descontinuadoH 1152 dihydrochloride
CAS:Inhibitor of Rho-kinase
Fórmula:C16H23Cl2N3O2SPureza:Min. 95%Peso molecular:392.34 g/molRef: 3D-FD22031
Produto descontinuado






